CVS stops sale of heartburn drugs with suspect contaminant

U.S. & World

** FILE ** Customers take advantage of the drive through pharmacy window outside a CVS drug store in a Bainbridge Twp., Ohio file photo from Aug. 3, 2006. Shareholders of drugstore chain CVS Corp. voted Thursday, March 15, 2007 to approve a deal to purchase pharmacy benefits manager Caremark Rx Inc. for about $26.5 billion in cash and stock. (AP Photo/Amy Sancetta, File)

CVS has halted sales of popular heartburn treatment Zantac and the store generic version after warnings by U.S. health regulators.

CVS is the latest retailer to pull the heartburn tablets from store shelves. Earlier this month, the U.S. Food and Drug Administration warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac.

In its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications such as Pepcid.

Some manufacturers of the drug have stopped distribution. Health officials say concerned patients should consult their doctor.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Video on

Don't Miss

Interactive Radar

More As Seen on 2 NEWS